Related Experiment Videos
Vagus nerve stimulation for medication-resistant generalized epilepsy. E04 VNS Study Group.
1New York Presbyterian Hospital-Cornell Medical Center, NY 10021, USA. drlabar@mail.med.Cornell.edu
Neurology
|May 5, 1999
Summary
Vagus nerve stimulation (VNS) significantly reduced seizures in generalized epilepsy patients. This effective treatment showed notable seizure rate reduction, particularly in those with higher baseline rates.
Area of Science:
- Neurology
- Neurosurgery
- Epileptology
Background:
- Generalized epilepsy is a challenging neurological condition.
- Medication-resistant epilepsy often requires alternative therapeutic strategies.
Purpose of the Study:
- To evaluate the efficacy of vagus nerve stimulation (VNS) in reducing seizure frequency.
- To identify patient characteristics associated with a positive response to VNS.
Main Methods:
- A prospective study involving 24 patients with generalized epilepsy.
- Seizure rates were compared during a 1-month baseline period versus 3 months of VNS therapy.
- Patient data included baseline seizure rates and age at epilepsy onset.
Main Results:
- Median seizure rate reduction was 46% with VNS.
- 16 out of 24 patients achieved >30% seizure reduction; 11 out of 24 achieved >50% reduction.
- Higher baseline seizure rates and later epilepsy onset correlated with better VNS response. Mild cough was the most common side effect.
Conclusions:
- Vagus nerve stimulation (VNS) is an effective treatment for medication-resistant generalized epilepsy.
- VNS demonstrates significant seizure reduction in pediatric and adult patients.
- Patient-specific factors like seizure burden influence treatment outcomes.